Condition: Lacunar Stroke · Stroke · Ischemic Stroke · Sponsor: Nippon Medical School
The goal of this clinical trial is to learn if a combination of antiplatelet drugs works better than intravenous tissue plasminogen activator to treat small ischemic stroke (lacunar stroke). The main questions it aims to answer are: Is a combination of antiplatelet drugs non-inferior to the current standard tissue plasminogen activator treatment? Does a combination of antiplatelet drugs reduce the bleeding complications than tissue plasminogen activator? Researchers will compare a combination of antiplatelet drugs to tissue plasminogen activator to see if a combination of antiplatelet drugs works to treat small ischemic stroke (lacunar stroke). Participants will: Take a combination of antiplatelet drugs or be given intravenous tissue plasminogen activator Check the neurological status 3 months after stroke, in-person, by phone, or by mail.
This description comes directly from the study's public registry record.
Yuki Sakamoto · +81-3-3822-2131 · yuki-sakamoto@nms.ac.jp
Always discuss trial participation with your own doctor first.
| University of Yamanashi Hospital | Chūō, Japan | Recruiting |
| University of Fukui Hospital | Fukui, Japan | Recruiting |
| Fukuoka Red Cross Hospital | Fukuoka, Japan | Recruiting |
| Ota Memorial Hospital | Fukuyama, Japan | Recruiting |
| Kansai Medical University Hospital | Hirakata, Japan | Recruiting |
| Kagoshima City Hospital | Kagoshima, Japan | Recruiting |
| Kagoshima Medical Center | Kagoshima, Japan | Recruiting |
| Shioda Hospital | Katsuura, Japan | Recruiting |
| St. Marianna University School of Medicine Hospital | Kawasaki, Japan | Recruiting |
| The Jikei University West Medical Center | Komae, Japan | Recruiting |
| Kawasaki Medical School Hospital | Kurashiki, Japan | Recruiting |
| Japanese Red Cross Kyoto Daini Hospital | Kyoto, Japan | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07111559